NCT06881056View on ClinicalTrials.gov

Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Respiratory Syncytial Virus (RSV)
Interventions
DRUG

Peginterferon α-2b injection

Peginterferon α-2b injection, 45 mcg, neb.On the 1st, 3rd, and 5th day, take the medication,while providing symptomatic and supportive treatment simultaneously.

DRUG

Peginterferon α-2b injection

Peginterferon α-2b injection, 90 mcg, neb.On the 1st, 3rd, and 5th day, take the medication,while providing symptomatic and supportive treatment simultaneously.

BEHAVIORAL

symptomatic and supportive treatment

symptomatic and supportive treatment

Trial Locations (2)

Unknown

RECRUITING

Chengdu Women's and Children's Central Hospital, Chengdu

RECRUITING

West China Second University Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

West China Second University Hospital

OTHER